WKN: | 852738 |
ISIN: | BE0003739530 |
Land: | Belgien |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die UCB-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 07. Oktober 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2024 | 78,60 | 191,45 | 143,58% |
2 | 2012 | 32,53 | 43,98 | 35,20% |
3 | 2025 | 191,45 | 253,40 | 32,36% |
4 | 2015 | 64,42 | 85,14 | 32,16% |
5 | 2006 | 39,80 | 52,30 | 31,41% |
6 | 2009 | 23,72 | 30,23 | 27,45% |
7 | 2004 | 29,85 | 37,50 | 25,63% |
8 | 2011 | 26,15 | 32,53 | 24,40% |
9 | 2013 | 43,98 | 53,83 | 22,40% |
10 | 2020 | 71,84 | 86,34 | 20,18% |
11 | 2014 | 53,83 | 64,42 | 19,67% |
12 | 2001 | 38,50 | 45,00 | 16,88% |
13 | 2021 | 86,34 | 100,85 | 16,81% |
14 | 2017 | 61,37 | 66,35 | 8,11% |
15 | 2018 | 66,35 | 71,30 | 7,46% |
16 | 2005 | 37,50 | 39,80 | 6,13% |
17 | 2023 | 74,34 | 78,60 | 5,73% |
18 | 2003 | 28,30 | 29,85 | 5,48% |
19 | 2019 | 71,30 | 71,84 | 0,76% |
20 | 2000 | 42,20 | 38,50 | -8,77% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2007 | 52,30 | 30,87 | -40,98% |
2 | 2002 | 45,00 | 28,30 | -37,11% |
3 | 2016 | 85,14 | 61,37 | -27,92% |
4 | 2022 | 100,85 | 74,34 | -26,29% |
5 | 2008 | 30,87 | 23,72 | -23,16% |
6 | 1999 | 52,15 | 42,20 | -19,08% |
7 | 2010 | 30,23 | 26,15 | -13,50% |
8 | 2000 | 42,20 | 38,50 | -8,77% |
9 | 2019 | 71,30 | 71,84 | 0,76% |
10 | 2003 | 28,30 | 29,85 | 5,48% |
11 | 2023 | 74,34 | 78,60 | 5,73% |
12 | 2005 | 37,50 | 39,80 | 6,13% |
13 | 2018 | 66,35 | 71,30 | 7,46% |
14 | 2017 | 61,37 | 66,35 | 8,11% |
15 | 2021 | 86,34 | 100,85 | 16,81% |
16 | 2001 | 38,50 | 45,00 | 16,88% |
17 | 2014 | 53,83 | 64,42 | 19,67% |
18 | 2020 | 71,84 | 86,34 | 20,18% |
19 | 2013 | 43,98 | 53,83 | 22,40% |
20 | 2011 | 26,15 | 32,53 | 24,40% |